Skip to main content
logo
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
1,822.40
+12.00 (0.66%)
Nov 7, 2025, 3:30 PM IST

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 32.64B INR in the quarter ending June 30, 2025, with 0.62% growth. This brings the company's revenue in the last twelve months to 134.56B, up 4.62% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.

Revenue (ttm)
134.56B
Revenue Growth
+4.62%
P/S Ratio
3.80
Revenue / Employee
8.52M
Employees
15,800
Market Cap
510.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025133.63B7.18B5.68%
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries549.64B
Aurobindo Pharma325.14B
Cipla279.66B
Zydus Lifesciences246.26B
Apollo Hospitals Enterprise225.51B
Biocon157.71B
Mankind Pharma135.09B
Alkem Laboratories133.04B
Revenue Rankings

Glenmark Pharmaceuticals News

More News